Heart stent gets Breakthrough status

Israel’s Endospan (reported here previously) has been granted Breakthrough Device Designation from the U.S. FDA for its NEXUS Aortic Arch Stent Graft System.  It already has the CE Mark of European approval.

https://www.businesswire.com/news/home/20200419005001/en/FDA-Grants-NEXUS%E2%84%A2-Aortic-Arch-Stent-Graft

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *